921MO Phase I global study of Iza-Bren (BL-B01D1), an EGFR x HER3 bispecific antibody-drug conjugate (ADC), in patients with metastatic or unresectable non-small cell lung cancer (NSCLC) and other solid tumors

Journal article

Peer reviewed

H.A. Yu, X. Le, M.L. Johnson, N. Iannotti, A.I. Spira, P.A. Jänne, M. Furqan, T. Patil, G. Lopes, C.A. Perez, …

Annals of oncology, Vol.36, pp.S601-S602

2025-09

Metrics

1 Record Views

Title: 921MO Phase I global study of Iza-Bren (BL-B01D1), an EGFR x HER3 bispecific antibody-drug conjugate (ADC), in patients with metastatic or unresectable non-small cell lung cancer (NSCLC) and other solid tumors
Creators: H.A. Yu
X. Le
M.L. Johnson
N. Iannotti
A.I. Spira
P.A. Jänne
M. Furqan
T. Patil
G. Lopes
C.A. Perez
W.J. Edenfield
S.V. Liu
Z. Piotrowska
C. Park
J.L. Zhao
H. Wang
G. Russo
H. Zhu
J. Cheng
J. Peguero
Publication Details: Annals of oncology, Vol.36, pp.S601-S602
Publisher: ELSEVIER
Number of pages: 2
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991032860826002976